245 related articles for article (PubMed ID: 26403563)
1. Evidence for the Relationship Between Endometriosis and Epithelial Ovarian Cancer.
del Carmen MG
Obstet Gynecol Surv; 2015 Sep; 70(9):587-95. PubMed ID: 26403563
[TBL] [Abstract][Full Text] [Related]
2. Targeted next-generation sequencing for molecular diagnosis of endometriosis-associated ovarian cancer.
Er TK; Su YF; Wu CC; Chen CC; Wang J; Hsieh TH; Herreros-Villanueva M; Chen WT; Chen YT; Liu TC; Chen HS; Tsai EM
J Mol Med (Berl); 2016 Jul; 94(7):835-47. PubMed ID: 26920370
[TBL] [Abstract][Full Text] [Related]
3. Unexpected epithelial ovarian cancers arising from presumed endometrioma: A 10-year retrospective analysis.
Kuo HH; Huang CY; Ueng SH; Huang KG; Lee CL; Yen CF
Taiwan J Obstet Gynecol; 2017 Feb; 56(1):55-61. PubMed ID: 28254227
[TBL] [Abstract][Full Text] [Related]
4. Aberrant expression of genes associated with stemness and cancer in endometria and endometrioma in a subset of women with endometriosis.
Ponandai-Srinivasan S; Andersson KL; Nister M; Saare M; Hassan HA; Varghese SJ; Peters M; Salumets A; Gemzell-Danielsson K; Lalitkumar PGL
Hum Reprod; 2018 Oct; 33(10):1924-1938. PubMed ID: 30020448
[TBL] [Abstract][Full Text] [Related]
5. The ARID1A pathway in ovarian clear cell and endometrioid carcinoma, contiguous endometriosis, and benign endometriosis.
Chene G; Ouellet V; Rahimi K; Barres V; Provencher D; Mes-Masson AM
Int J Gynaecol Obstet; 2015 Jul; 130(1):27-30. PubMed ID: 25912412
[TBL] [Abstract][Full Text] [Related]
6. Endometriosis-associated ovarian carcinoma (EAOC): an entity distinct from other ovarian carcinomas as suggested by a nested case-control study.
Erzen M; Rakar S; Klancnik B; Syrjänen K
Gynecol Oncol; 2001 Oct; 83(1):100-8. PubMed ID: 11585420
[TBL] [Abstract][Full Text] [Related]
7. Histopathology and ARID1A Expression in Endometriosis- Associated Ovarian Carcinoma (EAOC) Carcinogenesis Model with Endometrial Autoimplantation and DMBA Induction.
Wuyung PE; Rahadiati FB; Tjahjadi H; Salinah S; Kusmardi K; Kodariah R; Wiweko B
Asian Pac J Cancer Prev; 2021 Feb; 22(2):553-558. PubMed ID: 33639673
[TBL] [Abstract][Full Text] [Related]
8. [Epigenetic inactivation of SPOCK2 in the malignant transformation of ovarian endometriosis].
Ren F; Wang DB; Li T
Zhonghua Fu Chan Ke Za Zhi; 2011 Nov; 46(11):822-5. PubMed ID: 22333230
[TBL] [Abstract][Full Text] [Related]
9. Endometriosis-associated ovarian cancer is a single entity with distinct clinicopathological characteristics.
Li Q; Sun Y; Zhang X; Wang L; Wu W; Wu M; Meng C; Liu G
Cancer Biol Ther; 2019; 20(7):1029-1034. PubMed ID: 30913953
[No Abstract] [Full Text] [Related]
10. [Is endometriosis a precancerous lesion? Perspectives and clinical implications].
Chene G; Caloone J; Moret S; Le Bail-Carval K; Chabert P; Beaufils E; Mellier G; Lamblin G
Gynecol Obstet Fertil; 2016 Feb; 44(2):106-12. PubMed ID: 26850282
[TBL] [Abstract][Full Text] [Related]
11. The recent progress and therapy in endometriosis-associated ovarian cancer.
Su KM; Wang PH; Yu MH; Chang CM; Chang CC
J Chin Med Assoc; 2020 Mar; 83(3):227-232. PubMed ID: 31985569
[TBL] [Abstract][Full Text] [Related]
12. Loss of ARID1A-associated protein expression is a frequent event in clear cell and endometrioid ovarian cancers.
Lowery WJ; Schildkraut JM; Akushevich L; Bentley R; Marks JR; Huntsman D; Berchuck A
Int J Gynecol Cancer; 2012 Jan; 22(1):9-14. PubMed ID: 22193641
[TBL] [Abstract][Full Text] [Related]
13. Clinical analysis of ovarian epithelial carcinoma with coexisting pelvic endometriosis.
Wang S; Qiu L; Lang JH; Shen K; Yang JX; Huang HF; Pan LY; Wu M
Am J Obstet Gynecol; 2013 May; 208(5):413.e1-5. PubMed ID: 23220508
[TBL] [Abstract][Full Text] [Related]
14. Endometriosis-associated Ovarian Cancers.
Anglesio MS; Yong PJ
Clin Obstet Gynecol; 2017 Dec; 60(4):711-727. PubMed ID: 28990985
[TBL] [Abstract][Full Text] [Related]
15. Distinct β-catenin and PIK3CA mutation profiles in endometriosis-associated ovarian endometrioid and clear cell carcinomas.
Matsumoto T; Yamazaki M; Takahashi H; Kajita S; Suzuki E; Tsuruta T; Saegusa M
Am J Clin Pathol; 2015 Sep; 144(3):452-63. PubMed ID: 26276776
[TBL] [Abstract][Full Text] [Related]
16. Endometriosis-associated Ovarian Cancer: A Distinct Clinical Entity?
Bounous VE; Ferrero A; Fuso L; Ravarino N; Ceccaroni M; Menato G; Biglia N
Anticancer Res; 2016 Jul; 36(7):3445-9. PubMed ID: 27354606
[TBL] [Abstract][Full Text] [Related]
17. The origin of endometriosis-associated ovarian cancer from uterine neoplastic lesions.
Garavaglia E; Sigismondi C; Ferrari S; Candiani M
Med Hypotheses; 2018 Jan; 110():80-82. PubMed ID: 29317075
[TBL] [Abstract][Full Text] [Related]
18. Complement pathway is frequently altered in endometriosis and endometriosis-associated ovarian cancer.
Suryawanshi S; Huang X; Elishaev E; Budiu RA; Zhang L; Kim S; Donnellan N; Mantia-Smaldone G; Ma T; Tseng G; Lee T; Mansuria S; Edwards RP; Vlad AM
Clin Cancer Res; 2014 Dec; 20(23):6163-74. PubMed ID: 25294912
[TBL] [Abstract][Full Text] [Related]
19. An increased risk of epithelial ovarian cancer in Taiwanese women with a new surgico-pathological diagnosis of endometriosis.
Wang KC; Chang WH; Lee WL; Huang N; Huang HY; Yen MS; Guo CY; Wang PH
BMC Cancer; 2014 Nov; 14():831. PubMed ID: 25403543
[TBL] [Abstract][Full Text] [Related]
20. Differences in LINE-1 methylation between endometriotic ovarian cyst and endometriosis-associated ovarian cancer.
Senthong A; Kitkumthorn N; Rattanatanyong P; Khemapech N; Triratanachart S; Mutirangura A
Int J Gynecol Cancer; 2014 Jan; 24(1):36-42. PubMed ID: 24304685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]